ADAR1 Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

ADAR1 Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.41M	Buy	277,848 +9,457	+4%	+$315K	0.43%	55
2026 Q1	$8.08M	Buy	268,391 +32,420	+14%	+$1.04M	0.48%	51
2025 Q4	$7.36M	Sell	235,971 -31,845	-12%	-$785K	0.54%	41
2025 Q3	$5.41M	Sell	267,816 -78,062	-23%	-$1.37M	0.51%	47
2025 Q2	$5.8M	Sell	345,878 -177,889	-34%	-$2.87M	0.89%	31
2025 Q1	$8.05M	Buy	523,767 +377,096	+257%	+$6.74M	1.49%	14
2024 Q4	$3.23M	Buy	146,671 +38,500	+36%	+$700K	0.65%	36
2024 Q3	$1.95M	Buy	108,171 +5,050	+5%	+$88.4K	0.32%	53
2024 Q2	$1.68M	Buy	103,121 +1,495	+1%	+$23K	0.32%	47
2024 Q1	$1.43M	Sell	101,626 -9,700	-9%	-$122K	0.33%	54
2023 Q4	$1.16M	Buy	+111,326	New	+$1.04M	0.42%	41

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

ADAR1 Capital Management's TEVA Position: Q2 2026 in Review

ADAR1 Capital Management increased its Teva Pharmaceuticals (TEVA) stake by 3.5% in Q2 2026, buying an estimated $315K and bringing the position to 277,848 shares worth $9.41M. The position accounts for 0.43% of the portfolio, ranked #55.

ADAR1 Capital Management first reported a position in TEVA in Q4 2023 and has held it in 11 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

ADAR1 Capital Management held 277,848 shares of Teva Pharmaceuticals worth $9.41M as of Q2 2026.
ADAR1 Capital Management bought 9,457 Teva Pharmaceuticals shares in Q2 2026, an estimated $315K.
Teva Pharmaceuticals made up 0.43% of ADAR1 Capital Management's portfolio in Q2 2026, its #55 holding.
ADAR1 Capital Management first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.